Abstract: A nutraceutical and/or pharmaceutical composition designed to stimulate the production of type 2 beta-defensins. The composition includes as a sole active ingredient a gluco-oligosaccharide presenting the following basic oligomeric structure: for the treatment of intestinal inflammations in the quantity of 0.5 to 10 g. Application to the treatment of functional colopathy.

Abstract: A nutraceutical and/or pharmaceutical composition designed to stimulate the production of type 2 beta-defensins. The composition includes as a sole active ingredient a gluco-oligosaccharide presenting the following basic oligomeric structure: for the treatment of intestinal inflammations in the quantity of 0.5 to 10 g. Application to the treatment of functional colopathy.

Abstract: The invention relates to the fields of fatty substance chemistry, specifically of the ceramide-type compound synthesis. The invention resides substantially in the synthesis of ceramide-type compounds. Specifically, the aim of the invention is a new enzymatic synthesis method, comprising at least one amidification step and one esterification step, achieved through lipases, among fatty acids and/or esters thereof and amino alcohols. The resulting ceramide-type compounds can be used as cosmetic and/or pharmaceutical compositions, in particular as dermatological compositions in conjunction or in admixture with one or more suitable cosmetic and/or pharmaceutical excipients or carriers. The method has an interest particularly in the synthesis of active compounds useful in the fields of cosmetology and/or pharmacology and specifically of dermatology.

Abstract: This invention relates to the field of the chemistry of fats and more particularly to the synthesis of ceramide-type compounds. This invention substantially lies in the synthesis of ceramide-type compounds; more particularly, this invention has for an object a novel method of enzymatic synthesis including at least a step of amide formation and a step of esterification performed by lipases, between fatty acids and/or esters of fatty acids and amino-alcohols. The ceramide-type compounds thus obtained may be used in the form of cosmetic and/or pharmaceutical compositions, particularly dermatological, in combination or admixed with one or several excipients or vehicles suitable for cosmetics or pharmaceutics. This method finds an interest namely in the synthesis of active principles useful in the field of cosmetics and/or pharmaceutics and more particularly in the field of dermatology.